Post vaccine considerations for residents

Details

• Corporate Authors:
  National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
• Description:
  Updated Dec. 13, 2020
  
  Infection prevention and control considerations for residents of long-term care facilities with systemic signs and symptoms following COVID-19 vaccination
  
  Note: Strategies are needed by long-term care facilities to appropriately evaluate and manage post-vaccination signs and symptoms among their residents. The approach described in this document is intended to balance:
  
  • the risk of unnecessary testing and implementation of Transmission-Based Precautions for residents with only post-vaccination signs and symptoms with that of
  
  • inadvertently allowing residents with infectious COVID-19 or another transmissible infectious disease to expose others in the facility.
  
  While this guidance is intended for long-term care facilities, it could also be applied to patients in other healthcare settings. These considerations are based on the current understanding of signs and symptoms following COVID-19 vaccination, including timing and duration, and might change as experience with the vaccine accumulates.
  
  
• Subjects:
  Coronavirus Infections/prevention & Control COVID-19 Vaccines Drug-Related Side Effects And Adverse Reactions Long-Term Care Nursing Homes Vaccination Viral Vaccines
• Document Type:
  Webpage
• Place as Subject:
  United States
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha256:1f4560b109435e735b41d1e8acfe31cc49d149809700d98e713a933e04ebea3e
• Download URL:
  https://stacks.cdc.gov/view/cdc/98750/cdc_98750_DS1.pdf
• File Type:
  [PDF - 120.67 KB ]